Pavel Šmak , Robin Kotouček , Katarína Kostolanská , Eliška Bartečková , Jan Juřica , Libor Ustohal , Jana Hořínková , Pavla Linhartová , Ondřej Peš , Martin Čuta , Eva Táborská , Jana Gregorová
{"title":"Liquid chromatography mass spectrometry of segmented hair cortisol – A Bayesian retrospective window","authors":"Pavel Šmak , Robin Kotouček , Katarína Kostolanská , Eliška Bartečková , Jan Juřica , Libor Ustohal , Jana Hořínková , Pavla Linhartová , Ondřej Peš , Martin Čuta , Eva Táborská , Jana Gregorová","doi":"10.1016/j.jpba.2025.117127","DOIUrl":null,"url":null,"abstract":"<div><div>This study aimed to develop a robust methodology for quantifying cortisol decay in segmented human hair and to establish accurate retrospective estimates of initial cortisol levels. Two independent probabilistic approaches were employed: i) a Bayesian multilevel analysis across 37 individuals with 3–6 hair segments each and ii) a Bayesian repeated sampling approach in a single individual with 10 segments collected over eight months. All hair segments were analyzed for cortisol concentration using liquid chromatography-mass spectrometry with on-line solid phase extraction. Both approaches demonstrated an exponential decay pattern of cortisol in hair, with estimated decay constants (k) of 0.16 (95 % Credible interval: 0.10–0.22) and 0.11 (95 % Credible interval: 0.06–0.15), respectively. A correction factor was introduced to significantly enhance the accuracy of initial cortisol level estimation, enabling more reliable comparisons with reference intervals obtained from proximal hair segments. This innovative method has the potential to significantly improve long-term cortisol monitoring and advance clinical research especially in psychiatry and endocrinology.</div></div>","PeriodicalId":16685,"journal":{"name":"Journal of pharmaceutical and biomedical analysis","volume":"267 ","pages":"Article 117127"},"PeriodicalIF":3.1000,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmaceutical and biomedical analysis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0731708525004686","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0
Abstract
This study aimed to develop a robust methodology for quantifying cortisol decay in segmented human hair and to establish accurate retrospective estimates of initial cortisol levels. Two independent probabilistic approaches were employed: i) a Bayesian multilevel analysis across 37 individuals with 3–6 hair segments each and ii) a Bayesian repeated sampling approach in a single individual with 10 segments collected over eight months. All hair segments were analyzed for cortisol concentration using liquid chromatography-mass spectrometry with on-line solid phase extraction. Both approaches demonstrated an exponential decay pattern of cortisol in hair, with estimated decay constants (k) of 0.16 (95 % Credible interval: 0.10–0.22) and 0.11 (95 % Credible interval: 0.06–0.15), respectively. A correction factor was introduced to significantly enhance the accuracy of initial cortisol level estimation, enabling more reliable comparisons with reference intervals obtained from proximal hair segments. This innovative method has the potential to significantly improve long-term cortisol monitoring and advance clinical research especially in psychiatry and endocrinology.
期刊介绍:
This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome.
Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants.